EuroBiotech: More Articles of Note


> Anokion acquired Kanyos Bio and completed a $40 million series B financing. The acquisition gives Anokion ownership of a preclinical antigen-specific treatment for celiac disease. Statement 

> Genfit named Carol Addy as chief medical officer. Addy previously worked at Merck. Release 

> MaaT Pharma hired Emmanuel Prestat as computational biology manager. Prestat used to work at diagnostic business HalioDx. Statement 


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

> Ermium Therapeutics raised a €6.3 million series A round. The French biotech will use money to fund early-stage autoimmune research. Release 

> Kiadis Pharma confirmed it is still on track to bring ATIR101 to market in Europe next year. Statement 

Suggested Articles

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.

Durect’s share price fell 12% after half of the panel of painkiller experts recommended against approving Posimir.

China-based cancer and autoimmune disease biotech I-Mab Biopharma has raised $104 million on the U.S. Nasdaq composite.